My Account

Feligen®CRP/L

Feligen CRP is a modified, live vaccine that protects against the core diseases

Used for the active immunization of healthy kittens from 12 weeks of age and adult cats. This vaccine provides immunity against Feline calicivirus infection, rhinotracheitis, panleucopenia and feline leukaemia virus

FOR ANIMAL USE ONLY

Only for use by persons authorised thereto in terms of the Veterinary and Para-Veterinary Professions Act, 1982 (Act No. 19 of 1982).

 

Composition: Freeze-dried component per dose: Attenuated feline calicivirus strain F9 104.6-106.1 TCID50, attenuated feline rhinotracheitis virus strain F2 105-106.6 CID50, attenuated panleucopenia virus strain LR72 103.7-104.5 TCID50. Liquid component: Recombinant molecule of purified p45. feline leukaemia virus (FeLV) envelope antigen 102 μg/ml.

 

Warnings:

  • Vaccinate healthy cats only.
  • Vaccination of pregnant or lactating queens is not recommended.
  • Do not administer any corticosteroids or antiviral drugs preceding or following vaccination.
  • Feligen CRP/L vaccine can be used together with the Rabigen vaccine from 3 months of age.
  • Interactions between and with other products should not occur as long as normal veterinary practice for the immunisation of cats is followed.
  • Occasional hypersensitivity reactions may be observed in some animals. Immediate treatment for anaphylactic shock (adrenaline, antihistamines and corticosteroids) must be given.
  • In a small proportion of animals, slight watering of the eyes is sometimes noticed during the days following vaccination. It reduces spontaneously within a few days.
  • A transient malaise may be observed after vaccination. In very rare cases this may be accompanied by pyrexia, loss of appetite or vomiting. Clinical signs subside within 24-48 hours.
  • A slight and transitory swelling may occasionally be observed at the point of injection.
  • Keep out of reach of children and uninformed persons.
  • Although this vaccine has been extensively tested under a wide variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.

 

Precautions:

  • It is recommended that animals be treated for external and internal parasites at least 10 days prior to vaccination.
  • The vaccine should be administered in accordance with standard aseptic conditions for vaccination.
  • It is recommended that cats be checked for the presence of p27 circulating FeLV antigen, using the ELISA test, prior to vaccination as infection could render the vaccination ineffective.
  • Avoid exposure of the animal to infection for 21 days following vaccination.
  • Use the vaccine immediately after reconstitution.
  • Used needles, syringes and vials should be disposed of in a safe manner.

 

Directions for use: Use only as directed.

The vial containing the freeze-dried Feligen CRP/R should be reconstituted with 1 vial of Leucogen. Shake well. Use the vaccine immediately following reconstitution. Administer 1 ml subcutaneously.

Primary vaccination: Kittens of 8-9 weeks of age can be vaccinated with 1 ml of Feligen CRP/L, followed by another dose 3-4 weeks later (but never before the age of 12 weeks). Kittens older than 9 weeks can be vaccinated with 1 ml of Feligen CRP/L, followed by one dose of Feligen CRP/L one month later.

Booster vaccination: Annual revaccination with 1 ml of Feligen CRP/L.

 

Presentation: 10 x 1-dose vials of Feligen CRP with 10 x 1-dose vials of Leucogen packed in plastic container with package insert enclosed.

 

Storage instructions: Store at 2-8 °C. Protect from light. Do not freeze.

 

Registration numbers:

South Africa Reg. No: G3387 (Act 36/1947).

Namibia Reg. No: V06/24.2/917 NS2